Vir Biotechnology Inc

Healthcare · Biotechnology

11.50$ -0.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Vir Biotechnology Inc (VIR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,215 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VIR
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	0.0	–	–	192	457	457	423	512	477	672	943	919	1,136	1,058	1,210	1,954	2,887	2,619	2,696	2,802	2,666	2,244	2,045	1,919	1,794	1,670	1,498	1,399	1,308	1,193	1,019	1,003	1,026	1,215
Current Assets	188	–	–	118	98	377	338	403	378	579	850	772	993	862	1,066	1,563	2,568	2,288	2,414	2,519	2,359	1,946	1,769	1,588	1,213	1,206	1,047	1,042	932	736	546	514	523	574
Cash	-188	–	–	48	-98	81	94	109	168	372	463	437	521	742	715	348	812	1,505	964	849	825	667	452	242	161	297	168	223	274	211	170	234	276	279
Cash & Short-Term Investments	188	–	–	98	98	357	320	383	356	552	827	737	733	826	939	708	1,260	2,196	2,346	2,402	2,250	1,847	1,697	1,522	1,150	1,151	914	905	802	606	507	463	472	529
Receivables	0.0	–	–	–	0.0	0.0	–	–	–	3.8	–	1.9	225	0.6	93	773	1,223	7.0	6.2	26	18	13	4.8	12	9.8	7.2	5.3	5.1	–	5.2	4.0	3.6	–	22
Inventory	0.0	–	–	–	0.0	0.0	–	–	–	–	–	–	8.6	6.4	6.1	8.6	0.0	0.0	–	–	-6.9	0.2	8.4	–	–	0.0	-5.3	–	–	–	–	–	–	–
Property, Plant & Equipment	0.0	–	–	–	15	15	15	16	32	31	32	18	17	20	27	130	66	85	100	188	104	104	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	–	–	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17
Intangible Assets	0.0	–	–	37	36	36	36	36	35	35	34	34	34	34	33	33	33	33	33	33	33	26	25	23	22	19	19	8.1	8.1	8.0	7.9	7.9	7.8	7.7
Total Liabilities	0.0	–	–	371	55	55	703	88	97	108	131	202	485	320	334	522	886	667	546	724	695	434	370	329	247	236	258	248	264	245	223	238	213	232
Current Liabilities	0.0	–	–	40	41	41	44	59	56	55	77	99	361	146	234	341	702	478	308	511	485	226	165	175	94	96	117	120	137	105	75	93	74	95
Short-Term Debt	0.0	–	–	15	0.0	18	23	0.2	3.4	3.4	3.7	3.6	3.6	3.5	3.6	3.9	4.1	4.1	4.1	4.1	7.3	14	14	13	12	19	19	7.8	7.9	8.8	9.0	8.8	8.9	9.1
Accounts Payable	0.0	–	–	6.5	4.1	4.1	5.8	5.9	19	4.4	6.8	5.1	3.7	11	4.2	6.5	11	11	2.7	6.4	12	12	3.6	6.3	7.1	4.4	7.3	5.1	3.7	12	6.8	9.8	5.4	18
Long-Term Debt	0.0	–	–	–	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	225	–	–	-179	131	401	-281	424	380	564	812	717	651	737	876	1,432	2,001	1,952	2,150	2,078	1,971	1,810	1,675	1,590	1,547	1,434	1,241	1,150	1,044	947	796	765	813	982
Retained Earnings	0.0	–	–	-194	-256	-256	-305	-369	-446	-477	-562	-667	-836	-774	-664	-139	380	304	479	377	236	42	-122	-238	-303	-441	-655	-760	-881	-992	-1,155	-1,198	-1,323	-1,243
Shares Outstanding	7.0	7.0	97	97	97	109	109	92	108	115	126	127	128	134	134	134	135	132	135	133	134	134	134	135	135	136	137	137	137	138	139	139	147	169

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings